# Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants

> **NCT02163447** · PHASE3 · COMPLETED · sponsor: **Grant Dorsey, M.D, Ph.D.** · enrollment: 300 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy
- **DRUG:** 3 dose dihydroartemisinin-piperaquine (DP) for adult women during pregnancy
- **DRUG:** 3 dose sulfadoxine-pyrimethamine (SP) for adult women during pregnancy
- **DRUG:** Monthly dihydroartemisinin-piperaquine (DP) for infants
- **DRUG:** 3-monthly dihydroartemisinin-piperaquine (DP) for infants

## Key facts

- **NCT ID:** NCT02163447
- **Lead sponsor:** Grant Dorsey, M.D, Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-23
- **Primary completion:** 2018-05-14
- **Final completion:** 2018-05-14
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163447, "Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02163447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*